XML 41 R16.htm IDEA: XBRL DOCUMENT v3.25.0.1
OTHER LONG-TERM LIABILITIES
 12 Months Ended
Dec. 31, 2024
Other Liabilities Disclosure [Abstract]  
OTHER LONG-TERM LIABILITIES OTHER LONG-TERM LIABILITIES
The Company's other long-term liabilities were as follows:
December 31,
(in millions)20242023
Contingent consideration$— $2.3 
Escrow liability— 7.5 
Legal settlements— 24.0 
Other2.2 7.5 
Total other long-term liabilities$2.2 $41.3 
On October 23, 2023 (the "Effective Date"), the Company and Ravgen, Inc. ("Ravgen") entered into a settlement agreement pursuant to which the parties agreed to settle a pending lawsuit. Pursuant to the terms of the settlement agreement, the Company agreed to pay Ravgen a minimum of $12.8 million in three installment payments of $5 million, $5 million, and $2.8 million on or before October 31, 2023, October 31, 2024, and October 31, 2025, respectively. The Company also agreed to pay Ravgen $21.3 million in five annual installments beginning no earlier than January 1, 2026 if Ravgen successfully concluded in its favor all of Ravgen's litigations and patent reexaminations pending as of the Effective Date. As of the Effective Date, the Company determined that the payment of $21.3 million was probable and estimable. In the year ended December 31, 2024, based on updated information, the Company determined that the payment is no longer probable and reversed the accrual on the Consolidated Statements of Operations.